| Literature DB >> 31681669 |
S K Rai1, Manoj Kashid2, Barun Chakrabarty3, Vimal Upreti4, Omna Shaki5.
Abstract
BACKGROUND: Idiopathic adhesive capsulitis of shoulder is common cause of pain and restriction of shoulder motion between the ages of 30 and 65. The prevalence of adhesive capsulitis is as high as 10% to 22% in diabetes mellitus as compared normal population which is 02% and 04%. Therefore, the doubt arises whether patients developed adhesive capsulitis are at greater risk to develop diabetes mellitus and should be screen for diabetes so that it can be detected early.Entities:
Keywords: Adhesive capsulitis; blood glucose level; diabetes mellitus; frozen shoulder; screening
Year: 2019 PMID: 31681669 PMCID: PMC6820405 DOI: 10.4103/jfmpc.jfmpc_244_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Classification of glucose intolerance according to plasma glucose level
| Fasting Plasma Glucose, mmol/L (mg/dL) | Plasma Glucose after 2-hr OGTT, mmol/L (mg/dL) | |
|---|---|---|
| Normal glucose tolerance | <5.6 (100 mg%) | <7.8 (140 mg%) |
| Impaired fasting glucose | 5.6-6.9 (100-125 mg%) | |
| Impaired glucose tolerance | 7.8-11.1 (140-199 mg%) | |
| Diabetes mellitus | ≥7 (126 mg%) | ≥11.1 (200 mg%) |
Summary of WHO diagnostic criteria (1999) for diabetes and intermediate hyperglycaemia
| Classifications | Venous plasma glucose levels | |
|---|---|---|
| Normal | Fasting 2-h glucose | <6.1 mmol/l Not specified but <7.8 mmol/l implied |
| Diabetes | Fasting glucose 2-h glucose | ≥7.0 mmol/l or ≥11.1 mmol/l |
| IGT | Fasting glucose <8.0 mmol/l 2-h glucose | <7.0 mmol/l and ≥7.8 and <11.1 mmol/l |
| IFG | Fasting glucose 2-h glucose | ≥6.1 and <7.0 mmol/l and <7.8 mmol/l (if measured) |
Demographic and clinical factors of adhesive capsulitis shoulder patients in normal, diabetics
| Characteristics | In non-diabetic ( | Detected diabetic ( | Statistical difference, values | |
|---|---|---|---|---|
| Age (mean), years | 47.5 | 51.8 | t=0.48 | 0.31 |
| Female patients | 30 (22.2%) | 6 (4.4%) | 0.97 | |
| Manual worker, | 10 (7.4%) | 6 (35%) | 0.60 | |
| Patients from rural background, | 19 (14%) | 11 (65%) | 0.19 | |
| Involvements of both shoulder, | 10 (0.7%) | 5 (3.7%) | 0.74 | |
| Duration of adhesive capsulitis (mean), months | 7.47 | 5.35 | 0.21 | |
| Waist circumference (mean), cm | 47.9 | 91 | 0.01 | |
| Pain score (mean) | 53±14 | 56.7 | 0.24 | |
| Disability (SPADI) score (mean) | 47.5 | 51±15.5 | 0.13 |
Demographic and clinical factors of adhesive capsulitis shoulder patients in normal, pre-diabetics
| Characteristics | In non-diabetic ( | In pre-diabetic ( | Statistical difference, values | P (significant P<0.05) |
|---|---|---|---|---|
| Age (mean), years | 47.5 | 52.8 | 0.314 | |
| Female patients, | 30 (22.2%) | 11 (8.1%) | 0.933 | |
| Manual hard worker, | 10 (7.4%) | 13 (9.6%) | 0.612 | |
| Patients from rural region, | 19 (14%) | 20 (14.8%) | 0.191 | |
| Duration of adhesive capsulitis (mean), months | 7.47 | 5.65 | 0.221 | |
| Involvements of both shoulder, | 10 (0.7%) | 6 (4.4%) | 0.733 | |
| Waist circumference (mean), cm | 75 | 84 | 0.013 | |
| Pain score (mean) | 47.9 | 54.7 | 0.251 | |
| Disability (SPADI) score (mean) | 53±14 | 53±14.6 | 0.132 |
Prevalence of glucose intolerance/diabetes in different populations with similar ethnicities and age group to the present study
| Study | Population | Age Range | No. of Patients | Impaired Glucose Tolerance, % | |
|---|---|---|---|---|---|
| Yudkin JS[ | United kingdom | 35-70 | 88 | 32.95% | 0.002 |
| Modan M[ | Israel | 40-70 | 2040 | 19.6% | 0.003 |
| Kidwai et al.[ | India | 35-70 | 413 | 11% (in DM) | 0.001 |
| Mathew et al.[ | India | 40-65 | 310 | 16.45% | 0.005 |
| Dehghan et al. 2010[ | Iran | 510 | 13.30% (in DM) | 0.003 | |
| Cagliero et al. 2000[ | Massachusetts | 300 | 12% | 0.002 | |
| Present study | India | 30-65 | 135 | 15.5% pre-diabetics 20.7% (when IFG* and IGTT# included) 27.4% diabetic |
Summary of studies identifying diabetes in populations of adhesive capsulitis
| Study | Population | Number of patients | Prevalence |
|---|---|---|---|
| Tighe and Oakley 2008[ | USA | 88 | 38.6% |
| Milgrom et al. 2008[ | Israel | 224 | 29% |
| Wang et al. 2013[ | Australia | 263 | 20% (in AC) |
| Rauoof et al. 2004[ | Kashmir, India | 100 | 27% |
| Present study | India | 135 | 15.5% pre-diabetics 20.7% (when IFG* and IGTT# included) 27.4% diabetic. |
Footnote: *IFG: impaired fasting glucose; # IGGT: impaired glucose tolerance test